Πλοήγηση ανά Θέμα "fampridine"

Αποτελέσματα 1-2 από 2

Real-World Assessment of Quality of Life in Patients with Relapsing Remitting Multiple Sclerosis Treated with Teriflunomide for Two Years: Patient-Reported Outcomes from the AURELIO Study in Greece

Dardiotis E., Perpati G., Borsos M., Nikolaidis I., Tzanetakos D., Deretzi G., Koutlas E., Kilidireas C., Mitsikostas D.D., Hadjigeorgiou G., Grigoriadis N., Papagiannopoulos S., Orologas A., Aggelidakis P., Antonios A., Fakas N., Papadimitriou A., Iliopoulos I., Kostadima V., Karageorgiou K., Lamprakopoulos S., Nikiforidis D., Voumvourakis K., Kaponi A., Maltezou M., Acquaviva T.P., Kerezoudi E., Balamoutsos G., Kerasnoudis A., Mitsias P., Doskas T., Maris T., Baltogiannis C., Chroni E., The AURELIO investigators (2022)

Introduction: Multiple sclerosis (MS) is a highly heterogeneous inflammatory disease of the central nervous system. Patient-reported outcomes (PROs) in a real-world clinical setting can provide detailed information about ...
Tetracyclines Diminish In Vitro IFN-γ and IL-17-Producing Adaptive and Innate Immune Cells in Multiple Sclerosis

Florou D.T., Mavropoulos A., Dardiotis E., Tsimourtou V., Siokas V., Aloizou A.-M., Liaskos C., Tsigalou C., Katsiari C., Sakkas L.I., Hadjigeorgiou G., Bogdanos D.P. (2021)

Introduction: Limited data from clinical trials in multiple sclerosis (MS) reported that minocycline, a widely used antibiotic belonging to the family of tetracyclines (TCs), exerts a beneficial short-lived clinical effect ...